國家衛生研究院 NHRI:Item 3990099045/7765
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 914961      Online Users : 1428
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/7765


    Title: Recombinant lipidated dengue-4 envelope protein domain III elicits protective immunity
    Authors: Chiang, CY;Hsieh, CH;Chen, MY;Tsai, JP;Liu, HH;Liu, SJ;Chong, P;Leng, CH;Chen, HW
    Contributors: Division of Vaccine Research and Development
    Abstract: The combination of recombinant protein antigens with an immunostimulator has the potential to greatly increase the immunogenicity of recombinant protein antigens. In the present study, we selected the dengue-4 envelope protein domain III as a dengue vaccine candidate and expressed the protein in lipidated form using an Escherichia coli-based system. The recombinant lipidated dengue-4 envelope protein domain III folded into the proper conformation and competed with the dengue-4 virus for cellular binding sites. Mice immunized with lipidated dengue-4 envelope protein domain III without exogenous adjuvant had higher frequencies of dengue-4 envelope protein domain III-specific B cells secreting antibodies than mice immunized with the nonlipidated form. Importantly, lipidated dengue-4 envelope protein domain III-immunized mice demonstrated a durable neutralizing antibody response and had reduced viremia levels after challenge. The study demonstrates that lipidated dengue-4 envelope protein domain III is immunogenic and may be a potential dengue vaccine candidate. Furthermore, the lipidation strategy can be applied to other serotypes of dengue virus.
    Date: 2014-03
    Relation: Vaccine. 2014 Mar;32(12):1346-1353.
    Link to: http://dx.doi.org/10.1016/j.vaccine.2014.01.041
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0264-410X&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000333512600004
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84894455324
    Appears in Collections:[Hsin-Wei Chen] Periodical Articles
    [Chih-Hsiang Leng] Periodical Articles
    [Pele Choi-Sing Chong] Periodical Articles
    [Shih-Jen Liu] Periodical Articles

    Files in This Item:

    File Description SizeFormat
    SDO0264410X14000759.pdf1393KbAdobe PDF628View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback